On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes

Journal of General Virology

Volumn 90, Issue 4, 2009, Pages 799-809

  Rajamanonmani, Ravikumar ^a,e   Nkenfou, Celine ^b   Clancy, Paula ^c   Yau, Yin Hoe ^a   Shochat, Susana Geifman ^a   Sukupolvi Petty, Soila ^d   Schul, Wouter ^b   Diamond, Michael S ^d   Vasudevan, Subhash G ^c,e   Lescar, Julien ^a,f  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^c JAMES COOK UNIVERSITY   (Australia)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE NUS MEDICAL SCHOOL   (Singapore)

^f Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 9F12; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS REACTION; DENGUE VIRUS; EPITOPE MAPPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESIDUE ANALYSIS; SEROTYPE; VIRUS ENTRY; VIRUS INHIBITION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PLAQUE; VIRUS STRAIN; WEST NILE FLAVIVIRUS; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CERCOPITHECUS; CHEMISTRY; CLASSIFICATION; DENGUE; GENETICS; HAMSTER; IMMUNOLOGY; MEMBRANE FUSION; MOLECULAR GENETICS; SERODIAGNOSIS; SEROTYPING; VERO CELL;

DENGUE VIRUS; FLAVIVIRUS; WEST NILE VIRUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; CROSS REACTIONS; DENGUE; DENGUE VIRUS; EPITOPE MAPPING; MEMBRANE FUSION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; SEROTYPING; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 65549085229     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.006874-0     Document Type: Article

References (53)

1. Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W. & Heinz, F. X. (2001). Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75, 4268-4275.
2. Beasley, D. W. C. & Barrett, A. D. T. (2002). Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein. J Virol 76, 13097-13100.
3. Bhardwaj, S., Holbrook, M., Shope, R. E., Barrett, A. D. & Watowich, S. J. (2001). Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J Virol 75, 4002-4007.
4. Bressanelli, S., Stiasny, K., Allison, S. L., Stura, E. A., Duquerroy, S., Lescar, J., Heinz, F. X. & Rey, F. A. (2004). Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23, 728-738.
5. Chen, Y. (1997). Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 3, 866-871.
6. Chitarra, V., Alzari, P. M., Bentley, G. A., Bhat, T. N., Eisele, J. L., Houdusse, A., Lescar, J., Souchon, H. & Poljak, R. J. (1993). Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex. Proc Natl Acad Sci U S A 90, 7711-7715.
7. Chu, J. J. H., Rajamanonmani, R., Li, J., Bhuvanakantham, R., Lescar, J. & Ng, M. L. (2005). Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein. J Gen Virol 86, 405-412.
8. Clancy, P., Xu, Y., van Heeswijk, W. C., Vasudevan, S. G. & Ollis, D. L. (2007). The domains carrying the opposing activities in adenylyl-transferase are separated by a central regulatory domain. FEBS J 274, 2865-2877.
9. Cowieson, N. P., Wensley, B., Robin, G., Guncar, G., Forwood, J., Hume, D. A., Kobe, B. & Martin, J. L. (2008). A medium or high throughput protein refolding assay. Methods Mol Biol 426, 269-275.
10. Crill, W. D. & Roehrig, J. T. (2001). Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75, 7769-7773.
11. Dolezal, O., Pearce, L. A., Lawrence, L. J., McCoy, A. J., Hudson, P. J. & Kortt, A. A. (2000). ScFv multimers of the anti-neuraminidase antibody NC10: Shortening of the linker in single-chain Fv fragment assembled in VL to VH orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers. Protein Eng 13, 565-574.
12. Gromowski, G. D., Barrett, N. D. & Barrett, A. D. (2008). Characterization of dengue complex-specific neutralizing epitopes on the envelope protein domain III of dengue 2 virus. J Virol 82, 8828-8837.
13. Gubler, D. J. (2006). Dengue/dengue haemorrhagic fever: History and current status. Novartis Found Symp 277, 3-16 (discussion 16-22, 71-73, 251-253).
14. Halstead, S. B. (2007). Dengue. Lancet 370, 1644-1652.
15. Heinz, F. X. & Allison, S. L. (2003). Flavivirus structure and membrane fusion. Adv Virus Res 59, 63-97.
16. Hung, J. J., Hsieh, M. T., Young, M. J., Kao, C. L., King, C. C. & Chang, W. (2004). An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol 78, 378-388.
17. Kanai, R., Kar, K., Anthony, K., Gould, L. H., Ledizet, M., Fikrig, E., Marasco, W. A., Koski, R. A. & Modis, Y. (2006). Crystal structure of West Nile virus envelope glycoprotein reveals viral surface epitopes. J Virol 80, 11000-11008.
18. Karlsson, R. (1994). Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors. Anal Biochem 221, 142-151.
19. Keitel, T., Kramer, A., Wessner, H., Scholz, C., Schneider-Mergener, J. & Hohne, W. (1997). Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 91, 811-820.
20. Keller, T. H., Chen, Y. L., Knox, J. E., Lim, S. P., Ma, N. L., Patel, S. J., Sampath, A., Wang, Q. Y., Yin, Z. & Vasudevan, S. G. (2006). Finding new medicines for flaviviral targets. Novartis Found Symp 277, 102-114 (discussion 114-119, 251-253).
21. Kortt, A. A., Malby, R. L., Caldwell, J. B., Gruen, L. C., Ivancic, N., Lawrence, M. C., Howlett, G. J., Webster, R. G., Hudson, P. J. & Colman, P. M. (1994). Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex. Eur J Biochem 221, 151-157.
22. Lescar, J., Pellegrini, M., Souchon, H., Tello, D., Poljak, R. J., Peterson, N., Greene, M. I. & Alzari, P. M. (1995). Crystal structure of a cross-reaction complex between Fab F9.13.7 and guinea-fowl lysozyme. J Biol Chem 270, 18067-18076.
23. Lescar, J., Brynda, J., Rezacova, P., Stouracova, R., Riottot, M. M., Chitarra, V., Fabry, M., Horejsi, M., Sedlacek, J. & Bentley, G. A. (1999). Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody. Protein Sci 8, 2686-2696.
24. Lescar, J., Roussel, A.,Wien, M. W., Navaza, J., Fuller, S. D.,Wengler,G., Wengler, G. & Rey, F. A. (2001). The fusion glycoprotein shell of Semliki Forest virus: An icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 105, 137-148.
25. Lin, C. W. & Wu, S. C. (2003). A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol 77, 2600-2606.
26. Lisova, O., Hardy, F., Petit, V. & Bedouelle, H. (2007). Mapping to completeness and transplantation of a group-specific, discontinuous, neutralizing epitope in the envelope protein of dengue virus. J Gen Virol 88, 2387-2397.
27. Lok, S. M., Kostyuchenko, V., Nybakken, G. E., Holdaway, H. A., Battisti, A. J., Sukupolvi-Petty, S., Sedlak, D., Fremont, D. H., Chipman, P. R. & other authors (2008). Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nat Struct Mol Biol 15, 312-317.
28. Mandl, C. W., Allison, S. L., Holzmann, H., Meixner, T. & Heinz, F. X. (2000). Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol 74, 9601-9609.
29. Martina, B. E., Koraka, P., van den Doel, P., van Amerongen, G., Rimmelzwaan, G. F. & Osterhaus, A. D. (2008). Immunization with West Nile virus envelope domain III protects mice against lethal infection with homologous and heterologous virus. Vaccine 26, 153-157.
30. McBride, W. J. H. & Vasudevan, S. G. (1995). Relationship of a dengue 2 isolate from Townsville, 1993, to international isolates. Commun Dis Intell 19, 522-523.
31. Miller, J. L., deWet, B. J., Martinez-Pomares, L., Radcliffe, C. M., Dwek, R. A., Rudd, P. M. & Gordon, S. (2008). The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog 4, e17.
32. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2003). A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100, 6986-6991.
33. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2004). Structure of the dengue virus envelope protein after membrane fusion. Nature 427, 313-319.
34. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C. (2005). Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79, 1223-1231.
35. Navarro-Sanchez, E., Altmeyer, R., Amara, A., Schwartz, O., Fieschi, F., Virelizier, J. L., Arenzana-Seisdedos, F. & Despres, P. (2003). Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 4, 723-728.
36. Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S. & Fremont, D. H. (2005). Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437, 764-769.
37. Nybakken, G. E., Nelson, C. A., Chen, B. R., Diamond, M. S. & Fremont, D. H. (2006). Crystal structure of the West Nile virus envelope glycoprotein. J Virol 80, 11467-11474.
38. Oliphant, T., Engle, M., Nybakken, G. E., Doane, C., Johnson, S., Huang, L., Gorlatov, S., Mehlhop, E., Marri, A. & other authors (2005). Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11, 522-530.
39. Oliphant, T., Nybakken, G. E., Austin, S. K., Xu, Q., Bramson, J., Loeb, M., Throsby, M., Fremont, D. H., Pierson, T. C. & Diamond, M. S. (2007). Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol 81, 11828-11839.
40. Pokidysheva, E., Zhang, Y., Battisti, A. J., Bator-Kelly, C. M., Chipman, P. R., Xiao, C., Gregorio, G. G., Hendrickson, W. A., Kuhn, R. J. & Rossmann, M. G. (2006). Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN. Cell 124, 485-493.
41. Randolph, V. B. & Stollar, V. (1990). Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures. J Gen Virol 71, 1845-1850.
42. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375, 291-298.
43. Rezacova, P., Lescar, J., Brynda, J., Fabry, M., Horejsi, M., Sedlacek, J. & Bentley, G. A. (2001). Structural basis of HIV-1 and HIV-2 protease inhibition by a monoclonal antibody. Structure 9, 887-895.
44. Roehrig, J. T., Volpe, K. E., Squires, J., Hunt, A. R., Davis, B. S. & Chang, G.-J. J. (2004). Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein. J Virol 78, 2648-2652.
45. Sukupolvi-Petty, S., Purtha, W. E., Austin, S. K., Oliphant, T., Nybakken, G., Schlesinger, J. J., Roehrig, J. T., Gromowski, G. D., Barrett, A. D. & other authors (2007). Type- and sub-complex-specific neutralizing antibodies against domain III of dengue virus type-2 envelope protein recognize adjacent epitopes. J Virol 81, 12816-12826.
46. Summers, P. L., Cohen, W. H., Ruiz, M. M., Hase, T. & Eckels, K. H. (1989). Flaviviruses can mediate fusion from without in Aedes albopictus mosquito cell cultures. Virus Res 12, 383-392.
47. Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S. & other authors (2003). DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197, 823-829.
48. Thepparit, C. & Smith, D. R. (2004). Serotype-specific entry of dengue virus into liver cells: Identification of the 37-kilodalton/ 67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol 78, 12647-12656.
49. Throsby, M., Geuijen, C., Goudsmit, J., Bakker, A. Q., Korimbocus, J., Kramer, R. A., Clijsters-van der Horst, M., de Jong, M., Jongeneelen, M. & other authors (2006). Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile virus. J Virol 80, 6982-6992.
50. Thullier, P., Lafaye, P., Megret, F., Deubel, V., Jouan, A. & Mazie, J. C. (1999). A recombinant Fab neutralizes dengue virus in vitro. J Biotechnol 69, 183-190.
51. Thullier, P., Demangel, C., Bedouelle, H., Megret, F., Jouan, A., Deubel, V., Mazie, J.-C. & Lafaye, P. (2001). Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: Insight into the neutralization mechanism. J Gen Virol 82, 1885-1892.
52. Tio, P. H., Jong, W. W. & Cardosa, M. J. (2005). Two dimensional VOPBA reveals laminin receptor (LAMR1) interaction with dengue virus serotypes 1, 2 and 3. Virol J 2, 25.
53. Volk, D. E., Beasley, D. W. C., Kallick, D. A., Holbrook, M. R., Barrett, A. D. T. & Gorenstein, D. G. (2004). Solution structure and antibody binding studies of the envelope protein domain III from the New York strain of West Nile virus. J Biol Chem 279, 38755-38761.